References

Afrin, F., Chi, M., Eamens, A. L., Duchatel, R. J., Douglas, A. M., Schneider, J., ... & Dun, M. D. (2020). Can hemp help? Low-THC cannabis and non-THC cannabinoids for the treatment of cancer. Cancers, 12(4), 1033.

Baroi, S., Saha, A., Bachar, R., & Bachar, S. C. (2020). Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity: Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling. Dhaka University Journal of Pharmaceutical Sciences, 19(1), 47-58.

Cherkasova, V., Wang, B., Gerasymchuk, M., Fiselier, A., Kovalchuk, O., & Kovalchuk, I. (2022). Use of cannabis and cannabinoids for treatment of cancer. Cancers, 14(20), 5142.

Fraguas-Sánchez, A. I., Torres-Suárez, A. I., Cohen, M., Delie, F., Bastida-Ruiz, D., Yart, L., ... & Fernández-Carballido, A. (2020). PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In Vitro and In Ovo assessment. Pharmaceutics, 12(5), 439.

Gonçalves, E. C., Baldasso, G. M., Bicca, M. A., Paes, R. S., Capasso, R., & Dutra, R. C. (2020). Terpenoids, cannabimimetic ligands, beyond the cannabis plant. Molecules, 25(7), 1567.

Hardy, J., Haywood, A., Gogna, G., Martin, J., Yates, P., Greer, R., & Good, P. (2020). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1: 1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Trials, 21, 1-8.

Hasan, N., Imran, M., Sheikh, A., Saad, S., Chaudhary, G., Jain, G. K., ... & Ahmad, F. J. (2022). Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials. Journal of Drug Targeting, 30(7), 709-725.

Heblinski, M., Santiago, M., Fletcher, C., Stuart, J., Connor, M., McGregor, I. S., & Arnold, J. C. (2020). Terpenoids commonly found in Cannabis sativa do not modulate the actions of phytocannabinoids or endocannabinoids on TRPA1 and TRPV1 channels. Cannabis and cannabinoid research, 5(4), 305-317.

https://www.kaggle.com/datasets/corykjar/leafly-cannabis-strains-dataset

Johal, H., Devji, T., Chang, Y., Simone, J., Vannabouathong, C., & Bhandari, M. (2020). Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 13, 1179544120906461.

Khodadadi, H., Salles, É. L., Jarrahi, A., Chibane, F., Costigliola, V., Yu, J. C., ... & Baban, B. (2020). Cannabidiol modulates cytokine storm in acute respiratory distress syndrome induced by simulated viral infection using synthetic RNA. Cannabis and cannabinoid research, 5(3), 197-201.

Krüger, M., van Eeden, T., & Beswa, D. (2022). Cannabis sativa cannabinoids as functional ingredients in snack foods—Historical and developmental aspects. Plants, 11(23), 3330.

Lipnik-Štangelj, M., & Razinger, B. (2020). A regulatory take on cannabis and cannabinoids for medicinal use in the European Union. Archives of Industrial Hygiene and Toxicology, 71(1), 12-18.

Mahmoudinoodezh, H., Telukutla, S. R., Bhangu, S. K., Bachari, A., Cavalieri, F., & Mantri, N. (2022). The transdermal delivery of therapeutic cannabinoids. Pharmaceutics, 14(2), 438.

Rabgay, K., Waranuch, N., Chaiyakunapruk, N., Sawangjit, R., Ingkaninan, K., & Dilokthornsakul, P. (2020). The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis. Journal of the American Pharmacists Association, 60(1), 225-234.

Reddy, T. S., Zomer, R., & Mantri, N. (2023). Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids. Phytotherapy Research.

Riboulet-Zemouli, K. (2020). ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology. Drug Science, Policy and Law, 6, 2050324520945797.

Ritter, S., Zadik-Weiss, L., Almogi-Hazan, O., & Or, R. (2020). Cannabis, one health, and veterinary medicine: cannabinoids’ role in public health, food safety, and translational medicine. Rambam Maimonides Medical Journal, 11(1).

Sadhu, P. K., Rajput, A., Seth, A. K., Dash, D. K., Shah, N. V., Kumari, M., & Patel, S. (2020). A Combined Approach of Gold Nanoparticles with Cannabinoids for the Treatment of Cancer-A Review. International Journal of Pharmaceutical Research (09752366).

Sheriff, T., Lin, M. J., Dubin, D., & Khorasani, H. (2020). The potential role of cannabinoids in dermatology. Journal of Dermatological Treatment, 31(8), 839-845.

Turgeman, I., & Bar-Sela, G. (2019). Cannabis for cancer–illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. Expert Opinion on Investigational Drugs, 28(3), 285-296.

Uziel, A., Gelfand, A., Amsalem, K., Berman, P., Lewitus, G. M., Meiri, D., & Lewitus, D. Y. (2020). Full-spectrum cannabis extract microdepots support controlled release of multiple phytocannabinoids for extended therapeutic effect. ACS applied materials & interfaces, 12(21), 23707-23716.

Xiong, X., Chen, S., Shen, J., You, H., Yang, H., Yan, C., ... & Zhou, P. (2022). Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2. Signal Transduction and Targeted Therapy, 7(1), 99.

Yekhtin, Z., Khuja, I., Meiri, D., Or, R., & Almogi-Hazan, O. (2022). Differential effects of D9 tetrahydrocannabinol (THC)-and cannabidiol (CBD)-Based cannabinoid treatments on macrophage immune function in vitro and on gastrointestinal inflammation in a murine model. Biomedicines, 10(8), 1793.

Zenone, M., Snyder, J., & Caulfield, T. (2020). Crowdfunding cannabidiol (CBD) for cancer: hype and misinformation on GoFundMe. American Journal of Public Health, 110(S3), S294-S299.